ST
SRNE

Spot Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Spot Trading’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-41,662
Closed -$351K – 4194
2015
Q3 		$350K Buy
41,662
+35,103
+535% +$559K ﹤0.01% 2302
2015
Q2 		$116K Sell
6,559
-68,705
-91% -$883K ﹤0.01% 3034
2015
Q1 		$870K Buy
+75,264
New +$871K 0.01% 1700

Other funds holding SRNE

WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Spot Trading's SRNE Position: Q4 2015 in Review

Spot Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2015, closing a stake of 41,662 shares — an estimated $351K sold.

Spot Trading first reported a position in SRNE in Q1 2015 and held it in 3 quarters. The position peaked at $870K in Q1 2015. 84 funds tracked by Wall St. Rank hold SRNE as of Q4 2015.

  • Spot Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • Spot Trading sold 41,662 Sorrento Therapeutics, Inc. shares in Q4 2015, an estimated $351K.
  • Spot Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 3 quarters.
  • Spot Trading's Sorrento Therapeutics, Inc. position peaked at $870K in Q1 2015.
  • 84 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2015.

Based on Spot Trading's 13F filing for Q4 2015, filed 29 Jan 2016.